Overview

Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate tear film stability of a market lubricant therapeutic eye drop versus saline when using Evaporometry and Interferometry in patients with a diagnosis of Keratoconjunctivitis Sicca (KCS). The purpose of this research is to evaluate evaporative parameters and tear film quality when using Systane lubricating eye drops versus saline in the eyes of dry eye patients at pre-instillation and at 30 and 60 minutes post instillation of drop(s).
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Criteria
Inclusion Criteria: Individuals in good health with signs of Keratoconjunctivitis Sicca are
the primary subject population. An ophthalmologist will perform a thorough ocular exam in
order to assess entrance qualification into the clinical trial. Patients with apparent
Aqueous Tear Deficiency (ATD) with or without slit lamp findings of Meibomian lipid
turbidity or difficulty in expression of Meibomian Gland Secretion (MGD) with ocular
surface vital staining consistent with ATD in the absence of concurrent disease including
lid or ocular surface inflammation beyond 1+ bulbar conjunctival injection will be
enrolled.

-

Exclusion Criteria: Patients with active systemic disease or those taking systemic
medication that are known to influence AT production will not be considered for this trial.
In addition, patients using topical medication who are unable to discontinue them for at
least 24 hours prior to baseline evaluation will be excluded as well.

-